Prefilled Syringes Market Size

Prefilled Syringes Market size was over USD 18 billion in 2024 and is expected to cross USD 93.48 billion by the end of 2037, growing at more than 13.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of prefilled syringes is estimated at USD 19.94 billion.

The growth of the market can be attributed to the increasing prevalence of HIV and hepatitis-B cases. The self-filling needles used with patients who have hepatitis and HIV have frequently been used incorrectly. Therefore, prefilled syringes are the ideal treatment option for people with hepatitis and HIV. Further, the growing adoption of biologics and biosimilars, is also expected to add to the market growth. According to estimates, over 1,180,000 Americans had HIV in 2019.

In addition to these, factors that are believed to fuel the market growth of prefilled syringes include the rise in demand of self-injection devices. For instance, prefilled syringes are increasingly used to dispense self-administered medications such as anticoagulants, growth hormones, and insulin. Further, these syringes offer patients a quick, precise, and secure option to self-administer these medications.